0IL8.LKyntra Bio, Inc.

Über

Kyntra Bio, Inc. is a biopharmaceutical enterprise focused on the entire spectrum of therapeutic innovation, from discovering new compounds to developing and commercializing them. Leveraging profound insights into hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF) biology, the company strives to engineer effective medicinal solutions for anemia, fibrotic conditions, and various forms of cancer. Founded by Thomas B. Neff on September 29, 1993, Kyntra Bio, Inc. maintains its corporate headquarters in San Francisco, California.

www.kyntrabio.com

Kennzahlen

Marktkapitalisierung

30.30M

EPS

45.36

Dividendenrendite

0.00%

Beta

0.99

KBV

-1.17

EK-Rendite

-435.8%

Sektor

Healthcare

Branche

Medical - Pharmaceuticals

CEO

Thane Wettig

Mitarbeiter

225

IPO-Datum

2018-01-29

Land

US